Solvay PharmaceuticalsResearch and developmentClinical Trials DisclosureClinical Trial Results DatabaseClinical Trials Results - Androgel
This Site All Sites
 

 

 

Clinical Trials Results - Androgel

Generic Name: Testosterone
Form/Strengths:  Gel 1%
NDA number:  21-015
US label:  Androgel®


Study ID

Study Title

Study Results

Study publications

 S176.2.101 A Double-Blind, Randomized, Placebo-Controlled, Parallel Study to Evaluate the Efficacy and Safety of AndroGel®, as an Adjunct to Hypoglycemic Therapy, in the Treatment of Hypogonadal and Low Testosterone Men with Type 2 Diabetes Results summary

none available

 

 

 

 
accueil
© Solvay S.A • Important information : Privacy Policy  -  Disclaimer  -  Homepage • If you have any comments, please contact the webmaster
Date of last update: 21/10/2008